MIAMI, March 21, 2025 – Rubenstein Law, a firm specializing in mass torts and personal injury, is pleased to announce that Partner Miriam Fresco Agrait has been selected by the Honorable M. Casey Rodgers of the U.S. District Court for the Northern District of Florida to serve on the Data Administration Steering Subcommittee for the ongoing Depo-Provera litigation. This significant appointment recognizes Mrs. Agrait’s legal skill and dedication to achieving justice in complex pharmaceutical cases.

Mrs. Agrait’s extensive background in mass tort and product liability law makes her a valuable asset to the subcommittee. Her responsibilities will include helping to manage and organize essential data, ensuring the accuracy and availability of crucial case information.

“We are incredibly proud that Miriam has been appointed to this subcommittee,” stated Nicole Rubenstein Armstrong, CEO of Rubenstein Law. “Her commitment, experience, and knowledge will certainly aid in the fair and efficient management of this litigation.”

The Depo-Provera litigation stems from allegations that long-term use of Depo-Provera greatly increases the risk of developing meningioma, a serious type of brain tumor. The plaintiffs assert that the drug’s manufacturer failed to adequately inform users of this potential health risk.

Mrs. Agrait’s appointment further strengthens Rubenstein Law’s standing as a leading firm in mass tort and pharmaceutical litigation. The firm remains dedicated to advocating for those harmed by corporate negligence and ensuring that justice is served.

For media inquiries or more information, please contact:

Katie Amor
Chief Creative Officer
Rubenstein Law
786-230-2017

SOURCE Rubenstein Law

“`